Risk factors for post-treatment hypogonadism in testicular cancer patients.

European journal of endocrinology / European Federation of Endocrine Societies

Volumn 158, Issue 4, 2008, Pages 561-570

  Eberhard, Jakob ^a   Ståhl, Olof ^a   Cwikiel, Magdalena ^a   Cavallin Ståhl, Eva ^a   Giwercman, Yvonne ^a   Salmonson, Eva Cecilia ^a   Giwercman, Aleksander ^a  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ACT PROTOCOL; ANTINEOPLASTIC AGENT; CYTARABINE; DOXORUBICIN; TESTOSTERONE; TIOGUANINE; UNCLASSIFIED DRUG;

ADJUVANT CHEMOTHERAPY; ADJUVANT THERAPY; ADULT; ALGORITHM; ARTICLE; BLOOD; EVALUATION; FOLLOW UP; HUMAN; HYPOGONADISM; LONGITUDINAL STUDY; MALE; MULTIMODALITY CANCER THERAPY; NEOPLASM; ORCHIECTOMY; PROSPECTIVE STUDY; RADIATION INJURY; RADIOTHERAPY; RISK FACTOR; STONE FORMATION; TESTIS DISEASE; TESTIS TUMOR;

ADULT; ALGORITHMS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHEMOTHERAPY, ADJUVANT; COMBINED MODALITY THERAPY; CYTARABINE; DOXORUBICIN; FOLLOW-UP STUDIES; HUMANS; HYPOGONADISM; LITHIASIS; LONGITUDINAL STUDIES; MALE; NEOPLASMS, GERM CELL AND EMBRYONAL; ORCHIECTOMY; PROSPECTIVE STUDIES; RADIATION INJURIES; RADIOTHERAPY; RADIOTHERAPY, ADJUVANT; RISK FACTORS; TESTICULAR DISEASES; TESTICULAR NEOPLASMS; TESTOSTERONE; THIOGUANINE;

EID: 41749111603     PISSN: None     EISSN: 1479683X     Source Type: Journal    
DOI: 10.1530/EJE-07-0684     Document Type: Article

References (0)